Skip to main content
Avicanna Inc. logo

Avicanna Inc. — Investor Relations & Filings

Ticker · AVCN ISIN · CA05368K1003 LEI · 254900AUQ4URGWO3FN90 TSX Manufacturing
Open in API
Filings indexed 291 across all filing types
Latest filing 2026-04-21 AGM Information
Country CA Canada
Listing TSX AVCN

About Avicanna Inc.

https://www.avicanna.com/

Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of evidence-based, cannabinoid-based products for the global medical and pharmaceutical markets. The company operates through four commercial pillars: Medical Cannabis Products (RHO Phyto™), a Medical Cannabis Care Platform (MyMedi.ca), a Pharmaceutical Pipeline, and Active Pharmaceutical Ingredients (Aureus Santa Marta™). Avicanna leverages an industry-leading scientific platform, including R&D collaborations with academic institutions and a robust IP portfolio, resulting in over 50 proprietary commercialized SKUs.

Recent filings

Filing Released Lang Actions
News release - English.pdf
AGM Information Classification · 95% confidence The document is an announcement regarding the upcoming Annual General and Special Meeting of Shareholders scheduled for May 7, 2026. It provides details about the meeting date, proxy cut-off, and where meeting materials will be available. It does not contain the actual meeting materials or presentations but rather informs shareholders about the meeting logistics and availability of materials. The document length is 5515 characters, which is relatively short and consistent with an announcement rather than a full report. There is no financial data, detailed presentations, or voting results included. Therefore, this document fits the category of AGM Information (AGM-R), as it relates to the Annual General Meeting and provides information about it rather than the meeting materials themselves or voting results.
2026-04-21 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the agenda for the 6th Annual Clinical Symposium on Cannabinoid Therapeutics hosted by Avicanna Inc. It describes the event details, speakers, topics, and registration information. There is no financial data, regulatory filing, or report content. It is an announcement of an event rather than a financial or regulatory report. Therefore, it does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is best classified as a Regulatory Filing (RNS) since it is a general corporate announcement that does not fit other specific categories.
2026-04-20 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the agenda for the 6th Annual Clinical Symposium on Cannabinoid Therapeutics hosted by Avicanna Inc. It describes the event details, speakers, topics, and registration information. There is no financial data, regulatory filing, or report content. It is an announcement of an event rather than a financial or regulatory report. Therefore, it does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is best classified as a Regulatory Filing (RNS) since it is a general corporate announcement that does not fit other specific categories.
2026-04-20 English
Notice of meeting - English.pdf
Proxy Solicitation & Information Statement Classification · 90% confidence The document is a formal notice and proxy solicitation for an annual general and special shareholders’ meeting, directing shareholders to the Information Circular and proxy form and providing voting instructions. It is not the actual AGM presentation, not an earnings release, and not the results of a vote. Instead, it falls under the category of materials sent to shareholders to solicit votes and provide meeting information (Proxy Solicitation & Information Statement).
2026-04-16 English
Management information circular - English.pdf
Proxy Solicitation & Information Statement Classification · 98% confidence The document is a combined Notice of Annual General and Special Meeting of Shareholders and a detailed Management Information Circular (proxy statement) containing solicitation of proxies, voting procedures, and meeting agenda. It is not the company’s financial report itself, nor just an announcement of report publication. It is clearly a proxy solicitation and information statement sent to shareholders to request votes at the AGM. Therefore, it best fits the Proxy Solicitation & Information Statement category (PSI).
2026-04-16 English
Form of proxy - English.pdf
Capital/Financing Update Classification · 85% confidence The document is a completed Form 45-106F1 “Report of Exempt Distribution,” which is a Canadian regulatory filing detailing the issuance of securities under an exemption (i.e., a capital raising). It describes the terms of the distribution, purchasers, proceeds, and compensation paid, all of which constitute a financing update rather than an annual or interim report, share repurchase, board change, or other category. The most specific match in the taxonomy is Capital/Financing Update (CAP).
2026-04-16 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.